Embecta ROE 2021-2025 | EMBC
Current and historical return on equity (ROE) values for Embecta (EMBC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Embecta ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $0.10B | $-0.65B | -13.59% |
| 2025-06-30 | $0.09B | $-0.67B | -11.67% |
| 2025-03-31 | $0.05B | $-0.74B | -7.18% |
| 2024-12-31 | $0.06B | $-0.77B | -7.76% |
| 2024-09-30 | $0.08B | $-0.74B | -10.31% |
| 2024-06-30 | $0.07B | $-0.76B | -8.89% |
| 2024-03-31 | $0.07B | $-0.77B | -8.76% |
| 2023-12-31 | $0.06B | $-0.79B | -6.77% |
| 2023-09-30 | $0.07B | $-0.82B | -8.51% |
| 2023-06-30 | $0.05B | $-0.81B | -5.60% |
| 2023-03-31 | $0.09B | $-0.82B | -11.07% |
| 2022-12-31 | $0.16B | $-0.84B | -18.06% |
| 2022-09-30 | $0.22B | $-0.89B | -41.56% |
| 2022-06-30 | $0.34B | $-0.85B | -201.49% |
| 2022-03-31 | $0.38B | $-0.97B | 861.02% |
| 2021-12-31 | $0.41B | $0.55B | 142.88% |
| 2021-09-30 | $0.42B | $0.59B | 279.46% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.715B | $1.080B |
| Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $169.580B | 31.14 |
| HCA Healthcare (HCA) | United States | $106.416B | 17.62 |
| CVS Health (CVS) | United States | $104.957B | 12.07 |
| Elevance Health (ELV) | United States | $82.726B | 12.13 |
| Cencora (COR) | United States | $68.377B | 22.04 |
| Natera (NTRA) | United States | $33.600B | 0.00 |
| DiDi Global (DIDIY) | China | $23.532B | 21.74 |
| Labcorp Holdings (LH) | United States | $22.381B | 17.07 |
| Medpace Holdings (MEDP) | United States | $17.078B | 42.40 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.157B | 0.00 |
| Viatris (VTRS) | United States | $15.249B | 5.68 |
| ICON (ICLR) | Ireland | $15.081B | 14.96 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.921B | 13.51 |
| Revvity (RVTY) | United States | $13.350B | 24.58 |
| CochLear (CHEOY) | Australia | $12.343B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.026B | 21.24 |
| Avantor (AVTR) | United States | $8.345B | 12.75 |
| Sonic Healthcare (SKHHY) | Australia | $7.987B | 0.00 |
| HealthEquity (HQY) | United States | $7.383B | 27.61 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.209B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.142B | 42.58 |
| Bausch + Lomb (BLCO) | Canada | $6.089B | 39.98 |
| PACS (PACS) | United States | $5.503B | 33.47 |
| Sotera Health (SHC) | United States | $5.369B | 25.89 |
| Alignment Healthcare (ALHC) | United States | $4.724B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.945B | 51.72 |
| Concentras Parent (CON) | United States | $2.785B | 17.38 |
| Organon (OGN) | United States | $2.532B | 2.67 |
| Progyny (PGNY) | United States | $2.155B | 42.37 |
| Surgery Partners (SGRY) | United States | $2.044B | 26.33 |
| Establishment Labs Holdings (ESTA) | United States | $1.960B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.907B | 11.39 |
| Ardent Health (ARDT) | United States | $1.236B | 4.03 |
| Nutex Health (NUTX) | United States | $1.127B | 8.62 |
| Teladoc Health (TDOC) | United States | $1.127B | 0.00 |
| CareDx (CDNA) | United States | $1.081B | 17.66 |
| Omada Health (OMDA) | United States | $0.930B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.872B | 14.28 |
| InnovAge Holding (INNV) | United States | $0.806B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.685B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.596B | 0.00 |
| Enhabit (EHAB) | United States | $0.560B | 25.16 |
| CryoPort (CYRX) | United States | $0.547B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.489B | 0.00 |
| SBC Medicals (SBC) | United States | $0.459B | 8.43 |
| Auna S.A (AUNA) | Luxembourg | $0.419B | 6.74 |
| Agilon Health (AGL) | United States | $0.419B | 0.00 |
| Oncology Institute (TOI) | United States | $0.353B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.311B | 65.42 |
| Shoulder Innovations (SI) | United States | $0.310B | 0.00 |
| So-Young (SY) | China | $0.300B | 0.00 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| KindlyMD (NAKA) | United States | $0.177B | 0.00 |
| LifeMD (LFMD) | United States | $0.174B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Biodesix (BDSX) | United States | $0.088B | 0.00 |
| DocGo (DCGO) | United States | $0.083B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.55 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |